C WorldWide Group Holding A S lifted its holdings in shares of K2M Group Holdings Inc (NASDAQ:KTWO) by 15.0% in the 4th quarter, HoldingsChannel reports. The firm owned 231,368 shares of the medical device company’s stock after acquiring an additional 30,176 shares during the period. C WorldWide Group Holding A S’s holdings in K2M Group were worth $4,165,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Goldman Sachs Group Inc. grew its holdings in shares of K2M Group by 82.3% during the second quarter. Goldman Sachs Group Inc. now owns 211,585 shares of the medical device company’s stock worth $5,154,000 after purchasing an additional 95,548 shares in the last quarter. Ameriprise Financial Inc. purchased a new position in shares of K2M Group during the second quarter worth about $1,664,000. Oppenheimer Asset Management Inc. purchased a new position in shares of K2M Group during the third quarter worth about $347,000. Prudential Financial Inc. grew its holdings in shares of K2M Group by 12.3% during the third quarter. Prudential Financial Inc. now owns 303,930 shares of the medical device company’s stock worth $6,446,000 after purchasing an additional 33,200 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of K2M Group by 83.0% during the third quarter. Bank of New York Mellon Corp now owns 380,637 shares of the medical device company’s stock worth $8,073,000 after purchasing an additional 172,650 shares in the last quarter. 98.84% of the stock is owned by institutional investors.
Several research analysts have recently commented on KTWO shares. Zacks Investment Research lowered K2M Group from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. BidaskClub lowered K2M Group from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Wells Fargo & Co lowered K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price objective for the company. in a report on Monday, December 4th. Needham & Company LLC lowered K2M Group from a “strong-buy” rating to a “buy” rating and cut their price objective for the stock from $26.00 to $20.00 in a report on Friday, December 8th. Finally, Barclays reissued a “buy” rating and set a $25.00 price objective on shares of K2M Group in a report on Tuesday, January 9th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company. K2M Group currently has an average rating of “Buy” and an average target price of $24.50.
ILLEGAL ACTIVITY WARNING: This article was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.com-unik.info/2018/02/10/k2m-group-holdings-inc-ktwo-stake-lifted-by-c-worldwide-group-holding-a-s.html.
About K2M Group
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Want to see what other hedge funds are holding KTWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for K2M Group Holdings Inc (NASDAQ:KTWO).
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.